45,88 This is consistent with a substantial overlap between the two syndromes with respect to biological vulnerability.89 Yet, dysfunctional gamma-band activity may not extend to other disorders, such as personality or mood disorders.90 We would like to note that the wide range of oscillation frequencies 17-AAG provides a rich parameter field that can likely be exploited to delineate

disorder-specific neuronal dynamics. If successful, such frequency-specific markers Inhibitors,research,lifescience,medical could then be used to identify the underlying physiological mechanisms and perhaps be used to assign patients to novel disease categories. Fingerprints of neuronal dynamics, such as alterations in the frequency, temporal precision, phase locking, and topology of neuronal oscillations, both during processing and resting state, may provide novel criteria for differential diagnoses. Resting-state activity may be particularly suited for this purpose

because it has been shown Inhibitors,research,lifescience,medical to be highly structured,91 genetically determined,92 and to most Inhibitors,research,lifescience,medical likely reflect the coherent activation of functional networks that maintain representations of internal states.93 Implications for treatment and prevention The data reviewed may already have implications for a targeted search of novel treatments and preventive efforts. In view of the converging evidence for disturbed E/I balance and the resulting changes in high-frequency oscillations that are caused by alterations in GABAergic and glutamatergic neurotransmission, it might be rewarding to search for Inhibitors,research,lifescience,medical drug targets that restore E/I balance. Evidence on the efficacy of this approach is

still sparse with some treatments showing modest benefits94 while others failed to improve, for Inhibitors,research,lifescience,medical example, cognition in patients with schizophrenia.95 Treatment strategies should also consider that circuit dynamics may undergo changes during the course of the disorder. Accordingly, different interventions may be required at different phases.96 Proton magnetic resonance spectroscopy (1-H MRS) has revealed, for example, that GABA and glutamate concentrations are increased in unmedicated, first-episode patients but reduced in chronically medicated patients,66 suggesting that E/I balance shifts during the course of the illness. Another possibility for therapeutic interventions is suggested by the protracted Batimastat developmental Paclitaxel microtubule trajectory of brain dynamics that undergoes marked changes in late adolescence. The manifestation of schizophrenia during the transition from late adolescence to adulthood is preceded by an extended period of mild psychotic symptoms and cognitive dysfunctions97,98 and improvement in therapeutic success will very likely involve early interventions that should ideally be initiated prior to the full manifestation of the clinical symptoms.